KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Asset Utilization Ratio (2009 - 2026)

Abbott Laboratories recorded quarterly Asset Utilization Ratio of 0.46 in Q1 2026, down 11.74% quarter-over-quarter from 0.52 in Q4 2025, and down 11.95% year-over-year from 0.52 in Q1 2025.

Abbott Laboratories' Asset Utilization Ratio history runs 18 years deep, the most recent figure standing at 0.46 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 11.95% year-over-year to 0.46; the TTM figure through Mar 2026 stood at 0.46 (down 11.95% YoY), while the FY2025 annual figure was 0.53, down 2.82% from the prior year.
  • Asset Utilization Ratio came in at 0.46 for Q1 2026 at Abbott Laboratories, down from 0.52 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.15 in Q4 2022 to a low of 0.46 in Q1 2026.
  • A 5-year average of 0.64 and a median of 0.55 in 2023 frame the typical range for Asset Utilization Ratio.
  • Across the five-year window, Asset Utilization Ratio advanced 11.56% in 2022 and sank 52.14% in 2023, its largest moves.
  • Abbott Laboratories' Asset Utilization Ratio stood at 1.15 in 2022, then tumbled by 52.14% to 0.55 in 2023, then fell by 2.44% to 0.54 in 2024, then decreased by 3.68% to 0.52 in 2025, then slipped by 11.74% to 0.46 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.46, 0.52, and 0.52 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 0.37

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.46
Dec 31, 2025 0.52
Sep 30, 2025 0.52
Jun 30, 2025 0.52
Mar 31, 2025 0.52
Dec 31, 2024 0.54
Sep 30, 2024 0.56
Jun 30, 2024 0.56
Mar 31, 2024 0.55
Dec 31, 2023 0.55
Sep 30, 2023 0.55
Jun 30, 2023 0.55
Mar 31, 2023 1.08
Dec 31, 2022 1.15
Sep 30, 2022 0.61
Jun 30, 2022 0.61
Mar 31, 2022 1.10
Dec 31, 2021 1.06
Sep 30, 2021 0.58
Jun 30, 2021 0.55
Mar 31, 2021 0.99
Dec 31, 2020 0.96
Sep 30, 2020 0.47
Jun 30, 2020 0.46
Mar 31, 2020 0.89
Dec 31, 2019 0.86
Sep 30, 2019 0.46
Jun 30, 2019 0.45
Mar 31, 2019 0.46
Dec 31, 2018 0.44
Sep 30, 2018 0.43
Jun 30, 2018 0.42
Mar 31, 2018 0.39
Dec 31, 2017 0.37
Sep 30, 2017 0.35
Jun 30, 2017 0.33
Mar 31, 2017 0.36
Dec 31, 2016 0.45
Sep 30, 2016 0.52
Jun 30, 2016 0.52
Mar 31, 2016 0.50
Dec 31, 2015 0.49
Sep 30, 2015 0.48
Jun 30, 2015 0.47
Mar 31, 2015 0.48
Dec 31, 2014 0.48
Sep 30, 2014 0.48
Jun 30, 2014 0.47
Mar 31, 2014 0.46
Dec 31, 2013 0.45
Sep 30, 2013 0.46
Jun 30, 2013 0.48
Mar 31, 2013 0.38
Dec 31, 2012 0.33
Sep 30, 2012 0.42
Jun 30, 2012 0.50
Mar 31, 2012 0.57
Dec 31, 2011 0.65
Sep 30, 2011 0.63
Jun 30, 2011 0.60
Mar 31, 2011 0.60
Dec 31, 2010 0.60
Sep 30, 2010 0.61
Dec 31, 2009 0.62
Sep 30, 2009 0.63
Jun 30, 2009 0.67